Compass Wealth Management LLC Charles River Laboratories International, Inc. Transaction History
Compass Wealth Management LLC
- $392 Billion
- Q1 2025
A detailed history of Compass Wealth Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Compass Wealth Management LLC holds 233 shares of CRL stock, worth $34,898. This represents 0.01% of its overall portfolio holdings.
Number of Shares
233
Previous 233
-0.0%
Holding current value
$34,898
Previous $43 Million
18.46%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding CRL
# of Institutions
612Shares Held
54.9MCall Options Held
722KPut Options Held
847K-
Vanguard Group Inc Valley Forge, PA6.11MShares$914 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$762 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$642 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$358 Million0.07% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$343 Million0.63% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.62B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...